Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) EBITDA: 2015-2024

Historic EBITDA for Evolus (EOLS) over the last 10 years, with Dec 2024 value amounting to -$50.9 million.

  • Evolus' EBITDA rose 20.68% to -$15.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.0 million, marking a year-over-year decrease of 4.44%. This contributed to the annual value of -$50.9 million for FY2024, which is 17.61% up from last year.
  • Latest data reveals that Evolus reported EBITDA of -$50.9 million as of FY2024, which was up 17.61% from -$61.8 million recorded in FY2023.
  • Over the past 5 years, Evolus' EBITDA peaked at -$46.8 million during FY2021, and registered a low of -$163.0 million during FY2020.
  • For the 3-year period, Evolus' EBITDA averaged around -$62.5 million, with its median value being -$61.8 million (2023).
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 81.08% in 2020, then skyrocketed by 71.29% in 2021.
  • Over the past 5 years, Evolus' EBITDA (Yearly) stood at -$163.0 million in 2020, then soared by 71.29% to -$46.8 million in 2021, then tumbled by 59.69% to -$74.7 million in 2022, then grew by 17.36% to -$61.8 million in 2023, then climbed by 17.61% to -$50.9 million in 2024.